Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9112489 | 0.98 | MAPT (0.48) | DRD4KMT2AMEN1HTTIDO1 | |
| SCHEMBL14195530 | 0.86 | TP53 (0.48) | DRD4KMT2AMEN1MAPTKDM4E | |
| SCHEMBL9274672 | 0.86 | MAPT (0.54) | DRD4KMT2AMEN1HTTCYP3A4 | |
| SCHEMBL4671885 | 0.81 | MAPK1 (0.49) | KMT2AMEN1HTTTDP1MAPT | |
| SCHEMBL14176789 | 0.81 | RAB9A (0.47) | KMT2AMEN1KDM4E | |
| SCHEMBL1101359 | 0.77 | GAA (0.53) | DRD4KMT2AMEN1IDO1CYP3A4 | |
| SCHEMBL11661655 | 0.77 | IDO1 (0.52) | DRD4KMT2AMEN1HTTIDO1 | |
| SCHEMBL2126523 | 0.74 | FABP1 (0.48) | DRD4KMT2AMEN1IDO1THRB | |
| SCHEMBL1045802 | 0.74 | DRD2 (0.58) | DRD4KMT2AMEN1BCHEHPGD | |
| SCHEMBL507062 | 0.73 | CA4 (0.42) | TSHRMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11547115-B2 | Wettable agrochemical composition | NIPPON KAYUKU CO., LTD. (JP) | 2023-01-10 | — | — | US | claimed |
| CN-113024389-B | Preparation method of substituted phenoxybenzylamine compound and pyrazole carboxamide compound | 山东海利尔化工有限公司 | 2021-08-31 | — | — | CN | claimed |
| CN-113164451-A | Methods and compositions for treating glaucoma and related disorders | 奥库菲尔制药股份有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-113164452-A | Methods and compositions for treating presbyopia, mydriasis and other ocular disorders | 奥库菲尔制药股份有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-113024389-A | Preparation method of substituted phenoxybenzylamine compound and pyrazole carboxamide compound | 山东海利尔化工有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-112292035-A | Water-dispersible pesticide composition | 日本化药株式会社 | 2021-01-29 | — | — | CN | claimed |
| CN-1374861-A | Methods for modulating the human sexual response | ZONAGEN INC (US) | 2002-10-16 | — | — | CN | claimed |
| CN-117750948-A | Compositions and methods for targeted systemic delivery to cells | 瑞科德治疗公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117597327-A | Pharmaceutical preparation | 第一波动生物制药股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-111848494-B | Guanidine compounds and uses thereof | 伊谬诺米特医疗有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-110831584-B | Targeted drug rescue with novel compositions, combinations and methods thereof | 埃克塞瓦有限责任公司 | 2023-03-10 | — | — | CN | disclosed |
| US-11547115-B2 | Wettable agrochemical composition | NIPPON KAYUKU CO., LTD. (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-115216438-A | Preparation method and application of engineering myocardial tissue based on big blue flashing butterfly wing | 苏州大学 | 2022-10-21 | — | — | CN | disclosed |
| EP-0288515-A4 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS | — | 1990-09-26 | — | — | EP | disclosed |
| US-4830850-A | CONDITIONERS, SOFTENERS, PRESERVATIVES | GAF CORPORATION (US) | 1989-05-16 | — | — | US | disclosed |
| EP-0288515-A1 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS. | GAF CORP (US) | 1988-11-02 | — | — | EP | disclosed |
| WO-1988002985-A1 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS | GAF CORPORATION (US) | 1988-05-05 | — | — | WO | disclosed |
| EP-0049577-A1 | Alpha-cyanophenoxybenzylamine derivatives, processes for preparing them, and their use as intermediates for the preparation of pyrethroid insecticides | ICI AUSTRALIA LIMITED (AU) | 1982-04-14 | — | — | EP | disclosed |
| EP-0015456-B1 | OMEGA-HALOGENO-ACETOPHENONE OXIME ETHERS, PREPARATION THEREOF AND THEIR USE AS INTERMEDIATES IN THE PREPARATION OF OMEGA-AZOLYL-ACETOPHENONE OXIME ETHERS | BAYER AG (DE) | 1981-12-02 | — | — | EP | disclosed |
| US-4293715-A | FUNGICIDES, BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11547115-B2 | Wettable agrochemical composition | CEL, AMY1A, PHOSPHO1 | DRD4 2771/4885KMT2A 943/4885MEN1 2790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.